You are here: Industry Insights > AnchorDx

News List

Twist Alliance Pan-Cancer Methylation Panel Global Launch Event - A Strategic Collaboration Between AnchorDx and Twist Bioscience for Pan-Cancer Liquid Biopsy prnasia
October 13, 2021
The Twist Alliance Pan-Cancer Methylation Panel (Pan-Cancer Panel), a solution for pan-cancer study including DNA methylation library preparation and targeted enrichment for next-generation sequencing (NGS)...
AnchorDx Jointly Publishes Clinical Research Paper: "Accurate Diagnosis of Pulmonary Nodules Using a Non-invasive DNA Methylation Test" prnasia
April 29, 2021
AnchorDx, a world-leading developer of cancer screening and early detection solutions, together with renowned thoracic experts from 14 top-tier hospitals in China, jointly published a clinical research paper entitled "Accurate Diagnosis of Pulmonary ...
AnchorDx Completes USD 40 Million Series C Financing to Advance Cancer Screening and Early Detection Programs prnasia
February 23, 2021
AnchorDx Medical Co., Ltd. announced the completion of a USD 40 million Series C financing. This round of financing was jointly led by OrbiMed, a world-renowned biomedicine and healthcare venture capital fund, and WuXi Huiying Investment ...